187 related articles for article (PubMed ID: 38781180)
1. Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology.
Ostojić M; Đurić A; Živić K; Grahovac J
PLoS One; 2024; 19(5):e0299685. PubMed ID: 38781180
[TBL] [Abstract][Full Text] [Related]
2. Nischarin expression may have differing roles in male and female melanoma patients.
Ostojić M; Jevrić M; Mitrović-Ajtić O; Živić K; Tanić M; Čavić M; Srdić-Rajić T; Grahovac J
J Mol Med (Berl); 2023 Aug; 101(8):1001-1014. PubMed ID: 37382661
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin.
Maziveyi M; Alahari SK
Cancer Res; 2015 Oct; 75(20):4252-9. PubMed ID: 26392073
[TBL] [Abstract][Full Text] [Related]
5. Expression of Nischarin negatively correlates with estrogen receptor and alters apoptosis, migration and invasion in human breast cancer.
Chang C; Wei W; Han D; Meng J; Zhu F; Xiao Y; Wu G; Shi X; Zhang L
Biochem Biophys Res Commun; 2017 Mar; 484(3):536-542. PubMed ID: 28131840
[TBL] [Abstract][Full Text] [Related]
6. Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
Eastlack SC; Dong S; Mo YY; Alahari SK
PLoS One; 2018; 13(6):e0198945. PubMed ID: 29912916
[TBL] [Abstract][Full Text] [Related]
7. Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and Tumor Growth.
Maziveyi M; Dong S; Baranwal S; Mehrnezhad A; Rathinam R; Huckaba TM; Mercante DE; Park K; Alahari SK
Cancer Res; 2019 May; 79(9):2152-2166. PubMed ID: 30635277
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nischarin expression attenuates rilmenidine-evoked hypotension and phosphorylated extracellular signal-regulated kinase 1/2 production in the rostral ventrolateral medulla of rats.
Zhang J; Abdel-Rahman AA
J Pharmacol Exp Ther; 2008 Jan; 324(1):72-8. PubMed ID: 17940198
[TBL] [Abstract][Full Text] [Related]
9. Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.
Dong S; Ruiz-Calderon B; Rathinam R; Eastlack S; Maziveyi M; Alahari SK
Int J Cancer; 2020 May; 146(9):2576-2587. PubMed ID: 31525254
[TBL] [Abstract][Full Text] [Related]
10. Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancer.
Snider H; Villavarajan B; Peng Y; Shepherd LE; Robinson AC; Mueller CR
Clin Epigenetics; 2019 Nov; 11(1):155. PubMed ID: 31675993
[TBL] [Abstract][Full Text] [Related]
11. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
12. Nischarin as a functional imidazoline (I1) receptor.
Zhang J; Abdel-Rahman AA
FEBS Lett; 2006 May; 580(13):3070-4. PubMed ID: 16678176
[TBL] [Abstract][Full Text] [Related]
13. Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells.
Jain P; Baranwal S; Dong S; Struckhoff AP; Worthylake RA; Alahari SK
J Biol Chem; 2013 May; 288(22):15495-509. PubMed ID: 23572524
[TBL] [Abstract][Full Text] [Related]
14. TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC).
Bunch B; Krishnan N; Greenspan RD; Ramakrishnan S; Attwood K; Yan L; Qi Q; Wang D; Morrison C; Omilian A; Bshara W; Pili R; Trump DL; Johnson C; Woloszynska A
Cell Cycle; 2019 Sep; 18(17):2055-2066. PubMed ID: 31318640
[TBL] [Abstract][Full Text] [Related]
15. Expression of integrin-binding protein Nischarin in metastatic breast cancer.
Chen J; Feng WL; Mo WJ; Ding XW; Xie SN
Mol Med Rep; 2015 Jul; 12(1):77-82. PubMed ID: 25695373
[TBL] [Abstract][Full Text] [Related]
16. Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer.
Okpechi SC; Yousefi H; Nguyen K; Cheng T; Alahari NV; Collins-Burow B; Burow ME; Alahari SK
Oncogene; 2022 Feb; 41(8):1079-1086. PubMed ID: 35064214
[TBL] [Abstract][Full Text] [Related]
17. Nischarin Regulates Secretion of Exosomes and Cancer Progression.
McAndrews KM; Kalluri R
Cancer Res; 2019 May; 79(9):2099-2101. PubMed ID: 31043427
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
19. Regulation of p21-activated kinase-independent Rac1 signal transduction by nischarin.
Reddig PJ; Xu D; Juliano RL
J Biol Chem; 2005 Sep; 280(35):30994-1002. PubMed ID: 16002401
[TBL] [Abstract][Full Text] [Related]
20. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
